Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-056752

Director acquired 168,573 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BUCHI J KEVIN Director 2026-08-11 Option exercise −168,573 $17.18 $2,896,084 93,499 I
Loading xslF345X06/wk-form4_1786652460.xml…